These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33433414)

  • 1. Correlation of cyclin D1, HER2, and AMACR expressions with histologic grade in bladder urothelial carcinomas.
    Karakaya YA; Oral E
    Indian J Pathol Microbiol; 2021; 64(1):84-90. PubMed ID: 33433414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade.
    Nahar R; Jinnah MSA; Karim SS; Alam MM; Khatun J; Kabir E; Aktar M
    Mymensingh Med J; 2024 Apr; 33(2):461-465. PubMed ID: 38557526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus.
    Shi XY; Bhagwandeen B; Leong AS
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):447-52. PubMed ID: 18665038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
    Yang CC; Chu KC; Chen HY; Chen WC
    Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer.
    Gunia S; May M; Scholmann K; Störkel S; Hoschke B; Koch S; Dietel M; Kristiansen G
    Virchows Arch; 2008 Aug; 453(2):165-70. PubMed ID: 18648853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
    Langner C; Rupar G; Leibl S; Hutterer G; Chromecki T; Hoefler G; Rehak P; Zigeuner R
    Virchows Arch; 2006 Mar; 448(3):325-30. PubMed ID: 16315020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis.
    Aboushousha T; Hammam O; Helal N; El Dahshan S
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):513-519. PubMed ID: 29480994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
    Takagi Y; Takashi M; Koshikawa T; Sakata T; Ohshima S
    Int J Urol; 2000 Oct; 7(10):366-72. PubMed ID: 11144504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia.
    Aron M; Luthringer DJ; McKenney JK; Hansel DE; Westfall DE; Parakh R; Mohanty SK; Balzer B; Amin MB
    Am J Surg Pathol; 2013 Dec; 37(12):1815-23. PubMed ID: 24225842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
    Alston ELJ; Zynger DL
    Diagn Pathol; 2019 Aug; 14(1):91. PubMed ID: 31419984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder.
    Suwa Y; Takano Y; Iki M; Takeda M; Asakura T; Noguchi S; Masuda M
    J Urol; 1998 Sep; 160(3 Pt 1):897-900. PubMed ID: 9720584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance.
    Li CF; Fang FM; Lan J; Wang JW; Kung HJ; Chen LT; Chen TJ; Li SH; Wang YH; Tai HC; Yu SC; Huang HY
    Clin Cancer Res; 2014 Dec; 20(23):6141-52. PubMed ID: 25384383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.
    Sgambato A; Migaldi M; Faraglia B; De Aloysio G; Ferrari P; Ardito R; De Gaetani C; Capelli G; Cittadini A; Trentini GP
    Int J Cancer; 2002 Feb; 97(5):671-8. PubMed ID: 11807796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
    Lee CC; Yamamoto S; Morimura K; Wanibuchi H; Nishisaka N; Ikemoto S; Nakatani T; Wada S; Kishimoto T; Fukushima S
    Cancer; 1997 Feb; 79(4):780-9. PubMed ID: 9024716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-methyl CoA racemase expression in renal cell carcinomas.
    Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
    Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer. Finbladder Group.
    Liukkonen T; Lipponen P; Raitanen M; Kaasinen E; Ala-Opas M; Rajala P; Kosma VM
    Urol Res; 2000 Oct; 28(5):285-92. PubMed ID: 11127704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.